EPA Requires Political Approval of Grants

An aide to President Donald Trump has final say over grants at the Environmental Protection Agency and has nixed close to $2 million of the agency’s awards.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, BILLY HATHORNIn an unprecedented move earlier this summer, US Environmental Protection Agency (EPA) head Scott Pruitt appointed John Konkus, an aide to President Donald Trump, to review the agency’s grant funding decisions and solicitations, according to an E&E News report published last month (August 17). To date, he has canceled funds for several programs connected to air pollution and watershed protection and suspended all grants destined for Alaska, a move that, according to The Washington Post, had placed more than $10 million on hold.

While details concerning the scope and method of the new vetting process are lacking, Konkus’s focus has been directed to grants associated with climate change, The Washington Post reports. The protocol marks an “ideological shift” from previous administrations’ policies and has prompted confusion and unease from EPA officials and members of Congress.

Senator Thomas Carper (D-DE) asked Pruitt to shed light on which of the EPA’s projects are being scrutinized, and took notice of a recent dip in funds to several blue states, according to The Washington Post report.

Former EPA employee Christine Todd Whitman tells The Washington Post that throughout her tenure under the George W. Bush administration, the President’s aides were not involved in funding decisions. “We didn’t do a political screening on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies